FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities

FDA approved Symvess, the first acellular tissue engineered vessel for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible.
Source: FDA Press Releases